Evommune, Inc. Common Stock (EVMN)
R&D Expense Growth
52.50%
Quarterly · Period ending:
EVMN R&D Expense Growth
Latest reported52.50%period ending
Latest reported52.50%period ending
EVMN Quarterly R&D Growth (QoQ) (0.00% → 52.50%)
Latest values, visible window
High-resolution chart · PNG
EVMN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 52.503% | |
| -15.1154% | |
| 3.8902% | |
| 0.0051% | |
| 36.7358% | |
| -7.6963% | |
| 17.0856% | |
| -47.2198% | |
| 216.824% | |
| 0% |